Cargando…

CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis

SIMPLE SUMMARY: Up to 50% of patients with chronic lymphocytic leukemia relapse within four years after anti-CD20-directed treatment with a need for a subsequent treatment, which can potentially include anti-CD20 agents again. To retrospectively study the influence of CD20 expression in CLL patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schilhabel, Anke, Walter, Peter Jonas, Cramer, Paula, von Tresckow, Julia, Kohlscheen, Saskia, Szczepanowski, Monika, Laqua, Anna, Fischer, Kirsten, Eichhorst, Barbara, Böttcher, Sebastian, Schneider, Christof, Tausch, Eugen, Brüggemann, Monika, Kneba, Michael, Hallek, Michael, Ritgen, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562902/ https://www.ncbi.nlm.nih.gov/pubmed/36230840 http://dx.doi.org/10.3390/cancers14194917

Ejemplares similares

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study
por: Verbeek, Martijn W. C., et al.
Publicado: (2021)

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
por: van Dongen, J J M, et al.
Publicado: (2012)

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
por: Kalina, T, et al.
Publicado: (2012)

The EuroFlow PID Orientation Tube for Flow Cytometric Diagnostic Screening of Primary Immunodeficiencies of the Lymphoid System
por: van der Burg, Mirjam, et al.
Publicado: (2019)

Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels
por: Sędek, Łukasz, et al.
Publicado: (2022)

Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients—A EuroFlow Study
por: Bras, Anne E., et al.
Publicado: (2022)

Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools
por: del Pino-Molina, Lucía, et al.
Publicado: (2021)

Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study
por: Brouwer, Nienke, et al.
Publicado: (2022)

EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine
por: van Dongen, J J M, et al.
Publicado: (2012)

EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System
por: van Dongen, Jacques J. M., et al.
Publicado: (2019)

EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children
por: Kalina, Tomas, et al.
Publicado: (2020)

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
por: von Tresckow, Julia, et al.
Publicado: (2022)

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBINED TIME-LIMITED TREATMENT WITH ANTI-CD20 ANTIBODY + IBRUTINIB, IDELALISIB OR VENETOCLAX IN THE GCLLSG CLL2-BAG, -BCG, -BIG AND -BIO PHASE-II TRIALS
por: Yosifov, Deyan, et al.
Publicado: (2023)

Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
por: Yoroidaka, Takeshi, et al.
Publicado: (2021)

Automated EuroFlow approach for standardized in-depth dissection of human circulating B-cells and plasma cells
por: Delgado, Alejandro H., et al.
Publicado: (2023)

Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT)
por: Ferreira-Facio, Cristiane de Sá, et al.
Publicado: (2021)

Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study
por: Lhermitte, Ludovic, et al.
Publicado: (2020)

Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
por: Cramer, Paula, et al.
Publicado: (2020)

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab
por: Fink, A M, et al.
Publicado: (2013)

Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma
por: Urushihara, Ryota, et al.
Publicado: (2023)

Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
por: Matarraz, Sergio, et al.
Publicado: (2023)

Mutations driving CLL and their evolution in progression and relapse
por: Landau, Dan A., et al.
Publicado: (2015)

Patient specific real-time PCR in precision medicine – Validation of IG/TR based MRD assessment in lymphoid leukemia
por: Schilhabel, Anke, et al.
Publicado: (2023)

Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?
por: Fürstenau, Moritz, et al.
Publicado: (2019)

Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube
por: Botafogo, Vitor, et al.
Publicado: (2020)

Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study
por: Al-Sawaf, Othman, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Pflug, Natali, et al.
Publicado: (2021)

P630: SAFETY AND TREATMENT ADHERENCE WITH ACALABRUTINIB IN VERY OLD (≥80Y) AND/OR FRAIL PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - INTERIM SAFETY ANALYSIS OF THE ONGOING PHASE-II CLL-FRAIL TRIAL
por: Simon, Florian, et al.
Publicado: (2023)

COVID-19 among fit patients with CLL treated with venetoclax-based combinations
por: Fürstenau, Moritz, et al.
Publicado: (2020)

Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects
por: Criado, Ignacio, et al.
Publicado: (2022)

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study
por: Karat, D, et al.
Publicado: (1999)

DEA 1 Expression on Dog Erythrocytes Analyzed by Immunochromatographic and Flow Cytometric Techniques
por: Acierno, M.M., et al.
Publicado: (2014)

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group
por: von Tresckow, Julia, et al.
Publicado: (2023)

FlowFP: A Bioconductor Package for Fingerprinting Flow Cytometric Data
por: Rogers, Wade T., et al.
Publicado: (2009)

flowDiv: a new pipeline for analyzing flow cytometric diversity
por: Wanderley, Bruno M. S., et al.
Publicado: (2019)

Flow cytometric techniques for isolating and analysing leucocytes
por: Rossi, Adriano G, et al.
Publicado: (2015)

Flow Cytometric Detection of Proliferative Cells in Leukemias
por: Wakita, Atsushi, et al.
Publicado: (1994)

Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis
por: Park, Min-Seung, et al.
Publicado: (2019)

Flow Cytometric Analysis of Efflux by Dye Accumulation
por: Whittle, Emily E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o59fkev0epdmkpvd14hpmehci8